Evidence map›Paper›PMID 42452774›Full record

ArticleJournal of clinical medicine2026

Prognostic Value of Skeletal Muscle Loss in Unresectable Hepatocellular Carcinoma Treated with TACE-Based Combination Therapy.

Ningjing Yang, Kaiyu Chen, Chongming Zheng, Puchuang Xu, Junhao Pan, Yuepeng Jin, Gang Chen, Wenhao Hu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ningjing YangDepartment of Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Kaiyu ChenDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Chongming ZhengDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.ORCID 0000-0001-5615-6942
Puchuang XuDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.ORCID 0009-0004-7431-6750
Junhao PanDepartment of Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Yuepeng JinDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.ORCID 0000-0002-6530-6815
Gang ChenDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Wenhao HuDepartment of Interventional Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.

Funding

Research Foundation of National Health Commission of China-Major Medical and Health Technology Project for Zhejiang Province WKJ-ZJ-2438
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

combination therapyhepatocellular carcinomaprognosissarcopeniaskeletal muscle losstransarterial chemoembolization

Identifiers

PMID42452774
PMCPMC13362567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.